In 2006, Bryan et al. clearly defined TNBC as mammary cancer characterized by lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) (2). This evidence concerns the gene PGR and breast cancer.